ImpriMed
Sungwon Lim is the Co-Founder & CEO at ImpriMed. Previously, Sungwon was a Research Scientist at ViroMed Co., Ltd. Sungwon holds a Bachelor of Science - BS in Chemical and Biomolecular Engineering from Korea Advanced Institute of Science and Technology.
ImpriMed
ImpriMed provides cutting-edge personalized medicine easily accessible for pets with blood cancer diseases.